Abstract:
Biopolymeric drug delivery systems enhance the bioavailability and therapeutic efficacy of poorly soluble bioactive compounds. In this study, chitosan (Chi), dextran (Dex), carboxymethyl dextran (mDex), lignin (L), and curcumin (Cu) were combined to develop materials with controlled release, antioxidant, and anti-inflammatory properties. The mechanical evaluation showed that Chi-mDex-L-Cu exhibited the highest diametral tensile strength (2.40 MPa), a 1233% increase compared to Chi-mDex-L, due to strong hydrogen bonding interactions between curcumin and matrix components. Curcumin release kinetics, modeled using the Weibull equation, demonstrated that Chi-mDex-L-Cu presented the slowest release rate, reducing the cumulative release by 55.66% as compared to Chi-L-Cu, ensuring prolonged bioactivity. Despite its controlled release, Chi-mDex-L-Cu retained 60% antioxidant and 70% anti-inflammatory activity, making it a promising sustained-release system. The biocompatibility assessment confirmed cell viability above 85%, with Chi-mDex-L-Cu showing a slight (~10%) reduction at higher concentrations while remaining non-cytotoxic. These findings suggest that Chi-mDex-L-Cu is a strong candidate for biomedical applications requiring prolonged therapeutic effects, such as osteoarthritis treatment.
